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ABSTRACT
Dynamic Nanochannels for Biosensing Applications
Joseph Oxborrow
Department of Electrical and Computer Engineering
Master of Science
Inexpensive label-free detection of biomarker panels in serum could revolutionize early
cancer diagnosis and treatment. Such detection capabilities may be possible with dynamic
nanochannels in conjunction with electrical impedance measurement. In Dr. Greg Nordin’s
lab I designed, fabricated and tested several iterations of these sensors with polydimethylsiloxane microfluidics. The final design yielded a dynamic nanochannel array sensor that
showed a 140% impedance change when exposed to 14µM bovine serum albumin in phosphate buffered saline. For the geometry and noise limits of the tested device, simulations
indicated that a minimum detectable concentration of 20pM with specifically bound streptavidin should be possible. However, the polydimethylsiloxane approach is also shown to be
problematic in meeting the trade-offs required for a practical device. Consequently, alternative materials and designs are suggested to reduce the minimum detectable concentration
to the high femtomolar range, which would be attractive for detection of many medical
biomarkers.
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Chapter 1
Introduction
Proteomic biomarker assays hold great promise for early detection of many diseases,
particularly various types of cancer [1] [2] [3]. However, this promise has not been realized
due to limitations in current sensing technology. Enzyme-linked immunoabsorbent assays
(ELISAs) are the gold standard for low concentration proteomic assays, but suffer because of
their time intensive and expensive nature [4]. Mass spectrometry has been identified as the
future leading sensor technology for sensing and identifying proteins. These machines have
many advantages over ELISA but their sensitivity is limited [5] [6] [7]. Unless the sensitivity
of mass spectrometry can be significantly improved a new proteomic sensing technology is
needed.
Table 1.1: Cancer Survival Rates

Stage

0

IA

IB

IIA

IIB

IIC

IIIA

IIIB

IIIC

IV

Lung (non-small cell)

-

49%

45%

30%

31%

-

14%

5%

-

1%

Colorectal

-

74%

74%

67%

59%

37%

73%

46%

28%

6%

93%

88%

88%

81%

74%

-

67%

41%

49%

15%

-

14%

12%

7%

5%

-

3%

3%

3%

1%

Breast
Pancreatic

Five year survival rates for the four deadliest types of cancer [8].

In the case of cancer, early diagnosis based on improved sensing technology is critical
to improving survival outcomes. The American Cancer Society estimates 159,480 deaths
due to lung cancer in 2013, with the other three deadliest types of cancer estimated at 4050,000 deaths each [8]. Table 1.1 shows survival rates for the four deadliest types of cancer
according to the cancer stage at first diagnosis. Stage 0 and I cancers are localized and easier
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to treat as demonstrated by the survival rates for these stages. In later stages, as the cancer
metastasizes, treatment becomes increasingly difficult and survival rates drop accordingly.
Early detection would cause the prognosis for thousands of patients to dramatically improve.
Developing an inexpensive proteomic sensor holds the promise of widespread cancer screening
and detection, enabling many more of these cancers to be successfully treated. An improved
proteomic sensor could also be utilized to track cancer growth and the effects of different
drugs, thereby allowing a more effective personalized treatment plan [2].
Several individual biomarkers have been found to correlate with different types of
cancer [7]. However, these correlations may not be as strong as required for meaningful
clinical testing. In 2006 Dalton and Friend pointed out that understanding cancer biomarkers
and their complex interactions with different types of patients would take large sample
sizes and extensive collaboration between cancer researchers [1]. They further noted that
in many cases detection of more than a single molecule is necessary for a test to have
predictive power. For example, prostate-specific antigen (PSA) is often used for prostate
cancer detection. Laxman et al. showed that in addition to screening PSA levels a larger
number of biomarkers could be harnessed to provide more accurate prostate cancer diagnosis
[9]. Kozak et al. showed that ovarian cancer diagnosis could be improved from a receiver
operating characteristic (a measure of a test’s accuracy with one being perfectly predictive)
of 0.833 when only using the biomarker CA125 to 0.933 when CA125 was combined with a
panel of biomarkers for diagnosis [10].
There are many avenues being explored in the search for a revolutionary proteomic
sensor. In conjunction with my research group, I had fabricated and tested microcantilever
sensors, which were promising in many areas but gave responses lower than needed for
biomarker screening [11]. During the search for a more effective protein sensor design we
desired a transduction method which was simple, well understood, and didn’t require the use
of a labeling molecule. Keeping the sensor label-free significantly reduces the cost and complexity of operation. We chose to explore the use of dynamic nanochannels with impedance
spectroscopy. Using this approach ionic conduction through a nanochannel is reduced when
analyte molecules are captured by receptors attached to the nanochannel walls.
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In this thesis I describe the design, fabrication, and testing of a dynamic nanochannel proteomic sensor. The fabrication was accomplished by Dr. Weisheng Hu and Tim
Gustafson, while the PDMS was fabricated by Ben Tsai. Dr. Ryan Anderson programmed
the LabVIEW Virtual Instruments used in testing. I bonded the PDMS to the quartz dies,
designed and fabricated clamps, prepared fluids, performed sensing experiments and modeled the sensors with simulations. I present these simulations to illustrate how the dynamic
nanochannel sensor should be able to detect biomarker concentrations in the picomolar range.
Such a sensor would make routine cancer screening possible.
This thesis is organized as follows. In Chapter 2 I review the literature on nanochannel
impedance based sensing to provide a reference point for the work described in this thesis.
In addition, I present the derivation of a formula for calculating the impedance change upon
monolayer biomarker attachment in triangular nanochannels.
In Chapter 3 I describe the process by which my colleagues and I went from the
concept of impedance sensing to fabricating and testing a dynamic nanochannel sensor.
Through this process we learned how ions behave in fluids as well as the difference between
valves closing to bulk fluid flow and sealing to ionic conduction. We also built and tested
many sensor designs, each increasing our knowledge of impedance sensing.
In Chapter 4 I describe a dynamic nanochannel sensor, its design, fabrication and
experimental characterization. This sensor was tested with bovine serum albumin (BSA)
nonspecifically bound to the nanochannel walls. The response from the sensor corresponded
to BSA coverage on the sensor walls. The BSA was introduced to the nanochannels in only
fifteen minutes and gave a strong response.
In Chapter 5 I look at the molecular flux at the sensors walls for the dynamic
nanochannel array compared to traditional nanochannels discussed in the literature. I show
that dynamic nanochannel arrays enable increased molecular flux to the sensing surfaces,
thereby reducing sensor response time. Simulation results for the minimum detectable concentration for different binding kinetics is presented.
In the Conclusion I discuss future work to be done with the dynamic nanochannel
sensor. I present several avenues for improving the response of the sensor which would allow
detection of sub-picomolar concentrations.
3

Chapter 2
Background
This chapter will explore the current literature on nanochannel impedance-based
sensing. The results of published impedance sensing papers are reviewed and the difficulty
of providing sufficient flow in nanochannel sensors is demonstrated. Finally, an equation
relating the nanochannel dimensions to the occluded cross-sectional area due to biomarker
capture is derived.
2.1

Impedance sensing
Published biological channel impedance sensing originates with Kasianowicz et al.

In 1996 they used a lipid bilayer membrane as a channel to determine lengths of RNA
and DNA chains [12]. Later, in 2002, Saleh and Sohn fabricated a PDMS nanochannel
and detected DNA with impedance measurements [13]. With this DNA detection method
a range of impedance sensors appeared that are called nanopore sensors [14] [15]. These
nanopore sensors work primarily with DNA and measure the impedance through a pore to
determine the DNA sequence as it passes through. There are still many challenges with
these sensors such as controlling the time of flight (TOF) through the nanopore, being able
to resolve different base pairings, and fabricating large arrays of nanopores. However, this
sensor technology is promising in the search to enable inexpensive genome sequencing [16].
In addition to the work done with nanopores some groups use nanochannels for similar TOF
calculations by placing the electrodes perpendicular to the nanochannel and detecting the
change in conductance as DNA transverses the length of the nanochannel [17] [18].
Some work in impedance spectroscopy has focused on detecting changes on the electrode surfaces upon biomarker attachment [19]. However, the ionic reactions taking place
on the surface of an electrode in serum are complex and not well understood such that it is
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difficult to use this as the basis for a stable, high sensitivity sensor. Instead, in this thesis I
consider impedance change in nanochannels through the mechanism of reduced conducting
cross sectional area as molecules that are taken up on the sidewalls partially block the channel. As discussed later, high ionic concentrations in solutions allow nanochannel conduction
effects to dominate [20] [21].
Though nanopore impedance sensors are well established in genomics [16], the investigation of nanochannel sensors in proteomics has been limited. In 2004 Stein et al.
reported surface effects in nanochannels during ionic impedance sensing [22]. In 2005 Karnick et al. used these effects to detect streptavidin binding to biotin-coated nanochannels
[20]. They explored the relationship between buffer concentration and conductance. They
found the conductance tracked well with the calculated bulk conductance until surface effects dominated at lower ionic concentrations. Modifying the surface of the device with
(3-aminoproypyl)trimethoxysilane (APTMS) and later sulfosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate (Sulfo-NHS-SS-Biotin) changed the conductance at lower ionic
concentrations but left conductance with higher ionic concentration buffer unchanged. This
concentration dependence suggests these nanochannel surfaces are charged and exhibit ionic
transport but that this effect is dominated by bulk conductance at higher concentrations
(higher than 10mM PBS for their system). Other groups confirmed their results [21]. Karnick et al. detected streptavidin in nanochannels. However, due to the small cross sectional
area of the nanochannels (their height was 30nm) it took 10 hours to introduce a 16µM
streptavidin solution to their device [20].
Schoch el al. worked on a nanochannel sensor with induced flow to decrease the
time required to introduce biomarkers to the nanochannels [23]. Like Karnick et al., they
biotinylated the nanochannel surfaces and detected specifically bound streptavidin. Their
primary contribution was exploring the link between response time and fluid velocity in
nanochannel sensors. They calculated with the diffusion constant of streptavidin and length
of the channels that at velocities above 3.1 mm s−1 some of the analyte may flow through
without attaching to the sensor walls. They also calculated that the shear forces at those
speeds could be enough to break the biotin-streptavidin bond. They introduced fluid by
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applying pressure with an external pump and tested velocities up to 22.9 mm s−1 . They
were able to detect 1nM streptavidin in under two hours in their nanochannel sensors [23].
Durand et al. also built a nanochannel sensor. Instead of working with the biotinstreptavidin system they used nonspecific BSA binding. They reported an electrical model of
the nanochannel sensor, explored how the impedance changed with frequency and discussed
the relationship between the pH of the buffer solution and the nanochannel conductance
change upon protein attachment. Their device seemed to be able to detect 600nM BSA
binding to the sensor walls, with flow times just over 10 minutes [24].
Afanasiev et al. have also reported a nanochannel impedance sensor. Their sensor is
based on complementary metal oxide semiconductor (CMOS) fabrication technology which
would make it easy to fabricate. However their nanochannel sensors are diffusion limited as
they are open on only one end. In addition the protein sensing capabilities of these sensors is
not yet confirmed [25]. Ali et al. also explored building an asymmetric nanochannel sensor
and saw some I-V curve changes on the introduction of 100 nM BSA to the sensor [26].
Escosura-Muñiz and Merkoçi built probably the most complete nanochannel impedance
sensors. They have demonstrated detection of the cancer marker CS15-3 in whole blood.
The nanochannels are fabricated in anodized aluminum oxide after which they are functionalized for the antigen or the IgG. Their approach sacrifices label-free detection by using gold
nanoparticles for signal amplification but these labels allow detection of 50 ng mL−1 CA15-3
and 2 µg mL−1 of human IgG. They estimate a 50 ng mL

−1

(330 pM) detection limit for

the human IgG [27].
DNA is considerably easier to detect with nanochannels than proteins due to its comparably large size. Nevertheless, protein nanochannel sensing has been demonstrated even
in whole blood. Here we seek to improve the detection limits and response time compared
to reported nanochannel impedance sensors. This improvement will be accomplished by
increasing analyte flow to the surface and thereby decreasing the time needed to attach a
specified number of biomarkers to sensor surfaces.

6

2.2

Nanochannel impedance derivation
This derivation is presented to enable easier calculations of detection limits and ex-

pected impedance change for a given sensor geometry and thickness of attached biomarker.

By taking the cross sectional area of a triangular nanochannel with a width w0 and a height
h0 and applying a layer of biomarkers causing
some ionic occlusion of thickness t, the percent
impedance change can be calculated compared
to a final width w2 and final height h2 (see Fig.
2.1). The initial cross sectional area is given by
area0 =

w0 h0
,
2

(2.1)

area2 =

w2 h2
.
2

(2.2)

and final by

The percent impedance change is calculated by
taking the final impedance minus the initial
impedance divided by the initial impedance
∆Ω =
Figure 2.1: Area change of
focused ion beam (FIB) milled
nanochannels on biomarker attachment.

or
∆Ω =

Ω2 − Ω0
,
Ω0

2l
σw2 h2

−

2l
σw0 h0

2l
σw0 h0

(2.3)

.

(2.4)

The initial width is related to the final width by subtracting twice the thickness of
the occluded layer
w2 = w0 − 2t,
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(2.5)

the final height is then
h2 =

h0 (w0 − 2t)
h0 w2
=
.
w0
w0

(2.6)

After plugging in variables and simplifying the equation we obtain is
∆Ω =

w02
− 1.
(w0 − 2t)2

(2.7)

This result is illuminating because as long as h0 is much larger than t the impedance change
depends primarily on the difference between w0 and 2t. The BSA molecules we use in our
experiments are believed to have an ellipsoidal structure with minor axis 34Å long and the
other axes both being 84Å long [28]. If the occluded thickness of a protein layer is w0 /20
then the impedance change will be 23%. With a layer w0 /10 thick the impedance change
will be 56%.
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Chapter 3
Design and Fabrication Process
3.1

Interdigitated electrodes
In this chapter I discuss the series of designs that eventually led to the development

of dynamic nanochannels for biosensing. The process began with microfabricated interdigitated electrodes placed in static PDMS flow channels. These first sensors gave inconsistent
results. My research group and I determined that the conduction through the fluid above
the interdigitated electrodes dominated conduction between the electrodes, thereby preventing consistent impedance changes where bacteria or biomolecules were captured between
electrode fingers. With this understanding we positioned valves over the interdigitated electrodes. When the valve membrane collapses on top of the electrodes, the conduction path is
limited to any fluid trapped between adjacent electrode fingers. Finally, we abandoned interdigitated electrodes and put microchannels or nanochannels under the valves; this evolved
into the dynamic nanochannel design that is discussed in Chapter 4.
To accomplish the goal of impedance sensing for biomolecules we first fabricated interdigitated electrodes. Instead of using impedance changes occurring on the surface of the
electrodes as has often been done [19] we wanted to examine changes in the ionic paths
between the electrodes. We started with interdigitated electrodes because they had the advantage of being simple and we could quickly integrate them with our current generation of
PDMS designs. We postulated that the small volume between electrode fingers closest to the
substrate surface would provide a significant fraction of the conduction between electrodes.
Therefore the goal of the interdigitated electrode design was to trap biomolecules on the surface between electrodes to reduce the volume of fluid closest to the substrate surface between
the fingers by the capture of whichever type of biomolecule for which we functionalized the
substrate surface.
9

3.1.1

Interdigitated electrodes in PMDS flow channels

(a) Schematic of Interdigitated Electrode Mask.

(c) Close-up of an electrode set.

(b) Die level close-up.

Figure 3.1: IDE schematics.

Our group had previously used microcantilevers for biosensing. As a starting point,
we took the PDMS layout we had designed for the microcantilever experiments and repurposed it for interdigitated electrode sensing runs. The height of the first electrode die
stayed the same as the microcantilever dies (1.2cm) but the width was expanded to 4cm (see
Fig. 3.1a). The microcantilever die had two microcantilever arrays. On the interdigitated
electrode die in these two areas two sets of interdigitated electrodes were placed (see Fig.
3.1b). We fabricated two electrode designs in each set; one with 2µm lines and spaces and
10

the other with 1µm lines and spaces. Both designs had areas of 32µm x 32µm (see Fig.
3.1c). Each set was numbered one through four, with one being closest to the top of the
die as oriented in Fig. 3.1b. Electrodes one and three have 1µm lines and spacings while
electrodes two and four have 2µm lines and spacings. Fabricated electrodes are shown in
Fig. 3.2a.

(a) Microscope photo of fabricated (b) Microscope photo of fabricated IDE
IDE.
functionalized with CSA.
Figure 3.2: Fabricated IDEs.

Fabrication
There were several versions of interdigitated electrodes fabricated before we arrived
at the sensor described in chapter 4. These designs used a similar fabrication process to the
one described below, although with different masks and die sizes.
First, a 100mm quartz wafer is dehydration baked in an oven at 150◦ C for 10 minutes.
After baking, an adhesion promoter, Surpass 4000 is spun on at 4000 rpm for one minute.
Next AZ2020 photoresist diluted 1:1 with propylene glycol methyl ether actetate (PGMEA)
is spun on at 2000 rpm for one minute then at 6000 rpm for two seconds. The photoresist
layer is then softbaked at 110◦ C for three minutes. UV exposure is performed for twelve
seconds in a Karl Zuess Mask Aligner (MA 150CC) at 6 mW/cm2 in vacuum contact mode.
MIF3000 in a 2:1 mixture with deionized (DI) water is then used to develop the photoresist
for about eleven minutes. Next, the wafer is rinsed with DI water, and an oxygen descum
11

is performed in a LF001 Plasma Barrel Etcher at 100W for 45 seconds. A 110nm layer of
aluminum is deposited on the wafer using a Denton Vacuum E-beam evaporator. A lift-off
step is then performed with acetone in an ultrasonic bath. As a protective layer during
dicing, Surpass 4000 is spun on at 4000 rpm for a minute and AZ3330 at 4000 rpm also for
a minute. A soft bake is performed at 90◦ C, then the wafer is diced into dies and finally the
dies are cleaned with acetone and isopropyl alcohol (IPA).

(a) Microscope image of the cross section
of a fabricated PDMS flow channel. The
thickness of the bottom membrane layer at
the center of the microchannel is 30µm.

(b) Image of PDMS mask used with the IDE
dies. This PDMS design was recycled from the
microcantilever experiments and shows microcantilever sets instead of electrodes.

Figure 3.3: IDE PDMS mask and fabricated PDMS cross section.

The PDMS was fabricated in two layers: the fluidic layer and the control layer. The
fluidic layer is situated between the PDMS control layer and the quartz die underneath (see
Fig. 3.3a). The fluidic layer contains the microfluidic channels (blue areas in Fig. 3.3b). The
control layer is situated on top of the fluidic layer and houses the control lines and valves
(green areas in Fig. 3.3b).
The fluidic layer is fabricated on a 100mm silicon wafer. The silicon is first dehydration baked at 150◦ C for 15 minutes. Hexamethyldisilazane (HMDS) is then evaporated as
a photoresist adhesion layer onto the wafer surface for 15 minutes, followed by spin coating
AZ50XT photoresist onto the wafer at 900 rpm for 60 seconds giving an initial thickness of

12

60µm for the fluidic mold. A soft bake is performed at 60◦ C for 10 minutes and then 125◦ C
for 3 minutes. The wafer is then left to hydrate in air for one hour. A hard contact exposure
is performed with the Karl Zuess Mask Aligner for 60 seconds. The fluidic mold is developed
for 6 minutes and 40 seconds in AZ-421K, 15 minutes in AZ-400K at a 1:3 dilution with
deionized (DI) water and 40 minutes in AZ-400K at a 1:4 dilution. After a reflow bake at
125◦ C for 3 minutes a mixture of 10:1 PDMS to curing agent (Sylgard 184, Dow Corning
Corp) which has been degassed for an hour is spun onto the wafer at 750 rpm for 80 seconds
giving a thickness of 12 µm. The PDMS is then cured by baking for an hour at 80◦ C.
To fabricate the control layer mold SU8-2025 photoresist is used. A wafer is dehydration baked and HMDS is applied as with the fluid layer process. SU-2025 is then spun onto
the wafer at 500 rpm for 6 seconds and then 4000 rpm for 30 seconds giving a photoresist
thickness of 24µm. A 4:1 mixture of PDMS to curing agent is degassed for an hour. The
PDMS mixture is then poured onto the wafer. The control layer is then baked at 80◦ C for
an hour resulting in a thickness of 2.1mm.
Finally, the control layer pieces are cut from the wafer, stamped with curing agent,
and bonded to fluidic layer pieces. The two layer PDMS piece is then stamped with curing
agent again and bonded to the quartz die as explained in [29]. The curing agent bonding
process can be accomplished with time and/or heat, ranging from leaving the pieces overnight
to placing on a hot plate at 90◦ C for 30 minutes .
Characterization
The first tests of the interdigitated electrodes were done primarily to characterize the
devices, enable us to develop a sensing protocol, and introduce us to the challenges associated
with impedance sensing. Accordingly, we ran the first sensing tests with bacteria. We chose
bacteria primarily for their large size in comparison to biomolecules and because they could
be resolved in an optical microscope allowing us to quickly check if they had bound on the
substrate surface between the electrode fingers. This gave us an additional check to see if
the impedance scans were behaving as expected.
The electrodes were functionalized for the bacteria by pipetting six drops of CSA121, a molecule which was being developed in Dr Paul Savage’s lab to specifically attach
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Figure 3.4: Measured impedance plotted as a function of frequency and time. The experiment
begins with DI water in the channel above the IDEs. At 60 seconds the channel valve opens, at
120 seconds the syringe pumps starts, at 240 seconds pumping stops, and finally at 270 seconds
the valve closes.

Figure 3.5: Results of a sensing experiment with DI water, buffer solutions (Tris & PBS),
growth medium (TSP), and bacteria (PA).
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to the bacteria, over the electrode regions (see Fig. 3.2b). PDMS was then bonded to the
wafer surface. The fluidic channels were filled with DI water and continuous scans were
taken as buffer solution was flowed into the channel. The higher ion content in the buffer
solution is evident around 150 seconds when the buffer has flowed over the electrodes and
the impedance has decreased (see Fig. 3.4). Single scans of impedance versus frequency in
two buffer solutions tris(hydroxymethyl)aminomethane (Tris) and phosphate buffered saline
(PBS), in tryptic soy broth, and finally impedance scans were taken with bacteria flowing
through the channel (see Fig. 3.5). After several experiments it was clear that having the
bacteria attach to the CSA-121 in flowing fluid wasn’t likely and when a binding event did
appear to happen we weren’t able to detect it. In Fig. 3.5 there is an example of the results
from this series of experiments. The red traces indicate impedance of the growth medium
prior to bacteria introduction while the black traces are with bacteria flowing through the
channel. The traces diverge only slightly for sensor 4 (dashed lines) around 100kHz while
for sensor 2 (solid lines) they look almost identical.
This design didn’t seem to be able to detect the comparatively large bacteria in open
channels. We reasoned the electric fields might be less concentrated between the electrode
fingers than we previously thought. An experiment taking impedance scans while increasing
the size of a droplet of PBS buffer solution above the electrodes showed the conductance
increasing almost linearly with droplet diameter. This experiment suggested the importance
of conductance paths through the top surfaces of the electrodes and fluid above the electrode
fingers. Zou et al. using finite element analysis software modeled the electric field strength
around interdigitated electrodes in fluid [30] which also suggested the relative importance of
the conduction paths through the top surfaces of the electrode fingers.
3.1.2

Interdigitated electrodes with PDMS valves
After the disappointing results with the IDEs in open channels and seeing the impor-

tance of the conduction through the volume above the electrodes we designed an innovative
valve closing method to concentrate the electric field lines between the electrode fingers (see
Fig. 3.6). Four extra valves were added to the PDMS design; each valve over one set of
electrodes. When the valves actuated the PDMS would collapse around the IDEs. The
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Figure 3.6: Image of PDMS mask used with the IDE dies, this PDMS fluidic layer (in blue)
design was recycled from previous iteration but has valves (in green) above the electrodes.

actuation pressure would determine the degree of PDMS conformation onto the IDE fingers.
When a light pressure was applied the PMDS would lightly press against the electrodes while
at the maximum pressure (around 30PSI) the PDMS would collapse much of the way into
the gaps between the electrode fingers. With the PDMS valves actuated onto the electrodes
at high pressures the fluid conduction path would be solely between the electrode fingers
allowing the biomolecules to impede a much larger portion of the conduction path.
In order to characterize these valves we ran a couple preliminary experiments. We
expected the volume of conducting fluid between electrode fingers would depend on the
pressure applied to the valve. This led us to run an experiment where we took impedance
scans as we varied the valve pressure from 2 to 5, 10, 20, and 30PSI with a 40mM Tris buffer
(see Fig. 3.7a) as well as a 250mM PBS buffer (see Fig. 3.7b). The results from the two
buffers looked similar. Without pressure being applied to the valve the impedance was low,
after application of pressure the impedances steadily increased until 20PSI at which point the
PDMS valve appears to have almost reached its limit in conforming around the electrodes;
increasing the pressure to 30PSI only slightly affected the impedance. Taking a scan in air
and looking at the lowest frequency queried (1kHz) the impedance is around 109 Ωs, however
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(a) Pressure ramps with 40mM Tris solution.

(b) Pressure ramps with 250mM PBS solution.
Figure 3.7: Pressure ramps with Die Q8 showing increasing impedance with increased pressure.
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at 30PSI for both buffers the impedance is slightly over 107 Ωs. This impedance suggests
the PDMS valves do not collapse completely into the channels but leave a conduction path
useful for biomolecular sensing.

Figure 3.8: Results of sensing runs with Q8; the valve was closed at 30PSI, both BSA and
streptavidin are 17µM solutions.

After characterizing the valves we ran a series of sensing experiments. We started
experimenting with bacteria but it wasn’t clear if with their size they should impede conduction paths, behave like tent poles propping up the PDMS valve, or rupture when pressed
with the PDMS valve. After brief experiments working with bacteria the data was inconclusive so we turned to a protein system we had worked with before: biotinylated BSA and
streptavidin.
The new protocol for sensing required taking scans in air before the introduction of
fluid after which buffer is flowed into the channels. Next, open and closed scans at 30PSI are
taken (PBS Buffer), biotinylated BSA is then introduced to the channels and a buffer rinse is
performed. After the rinse, open and 30PSI scans are taken (Post-BSA Buffer), streptavidin
is then flowed into the channels, a buffer rinse is performed, and the final set of scans are
taken (Post-Streptavidin Buffer) (see Fig. 3.8).
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Figure 3.9: Results of sensing runs with Q10; the valve was closed at 30PSI, both BSA and
streptavidin are 17µM solutions.

One electrode from one of the dies gave a promising result (see Fig. 3.8) but the
majority of the results didn’t look so promising (see Fig. 3.9 for example). Scans on Die
Q10 for buffer (Initial) and for BSA look quite similar in open and closed situations while
the results with streptavidin show slightly decreased impedance compared to the other two.
Perhaps the streptavidin results could be useful except for two things: first, the impedance
should increase not decrease as the biomolecules impede conduction between electrode fingers
and second, the results are inconsistent between experiments (see Fig. 3.14 for a case when
impedance increases with streptavidin). With the idea that these sensors could and should
work we went looking for the sources of our often conflicting results.
One of the first places we looked was at PDMS valve placement. By the nature of
the valve design and alignment error, the electrodes were seldom directly centered under
the valve membrane; a typical placement is shown in Fig. 3.10. Although one of the better
alignments the center of the valve is only centered above the 2nd and 3rd electrodes. We
noticed an electrode which gave promising results appeared to be particularly well aligned
under the valve. So we focused on valve placement to see if this was the source of variability.
However, we found that many of the electrodes where placement looked particularly good
had inconsistent results.
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Figure 3.10: Q10 Set 1 electrodes under PDMS.

The next suspect in our hunt for the source of the inconsistent results was electrode
thickness. Perhaps the PDMS valves were in many cases sealing off in between the valves and
giving results which didn’t seem to depend on the bound molecules (see Fig. 3.9). To this
end the electrodes were deposited to a greater thickness of 220nm and we tried electroplating
them to an even greater thickness. After running more tests this also seemed to be of no
avail.

Figure 3.11: Fluorescence image of Q10 Set 2 electrodes 1&2 after the sensing run.
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Finally we began to suspect the curing agent used in the PDMS fabrication and as
the bonding agent between the quartz substrate and the PDMS fluid layer. Fig. 3.11 is a
fluorescence image of one of the dies after a sensing run. The streptavidin had a fluorescent
tag allowing us to examine where the streptavidin had bound. In examining one of these
images we noticed a thick film above the electrodes which was broken in places. In Fig. 3.11
we see the thick layer folded above the electrode lines on the left side of both the electrode
lines. This film seemed too thick to consist of the BSA and streptavidin so we suspected
it was curing agent contaminating the surface during the bonding process. The PDMS is
stamped on a wafer which has been spun with a thin layer of curing and then is aligned and
placed on the quartz die. After placement, curing agent is heat cured at 70◦ C for 30 minutes
then at 90◦ for another 30 minutes. We postulated the heat cure volatilized the curing agent
and it redeposited in the electrode region or the curing agent had an affinity for the gold
surfaces of the electrodes and wicked across them sometime during the bonding process.

Figure 3.12: On the left Q14 Set 1 Electrode 2 before application of curing agent. On the
right an example of the electrode lines after application of curing agent. The fringes indicate
the presence of a thin transparent film on top of the gold electrodes.

To test if curing agent would in fact create a thick film on the surface of the die we
first ran a thermal deposition with a small amount of curing agent on a hot plate and a die
above it. Not surprisingly, a thick layer of curing agent deposited on the die; Fig. 3.12 shows
before and after microscope images. Unfortunately, it was difficult to see the clear film on
the small surfaces of the interdigitated electrodes but fringes on the larger electrode lines
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(a) Impedance measurements of Q14 Set 1 before and after application of curing agent.

(b) Impedance measurements of Q17 Set 1 Electrode 1 before and
after application of curing agent and PDMS.
Figure 3.13: Changes in impedance with application of curing agent with and without PDMS.
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made it more apparent. We then looked into how curing agent affected the impedance scans
by taking impedance measurements with and without curing agent on the device (see Fig.
3.13a). Buffer solution was placed on the electrode sets and scans were taken (dashed lines)
after which the sample was cleaned and a couple of droplets of curing agent were placed
on the device away from Set 1. The die was then placed on the hot plate at 90◦ C for 5
minutes. Scans with an equivalent amount of buffer solution were again taken (solid lines).
It appeared placement of curing agent could significantly contaminate the electrodes.
After determining that the use of curing agent caused contamination of the electrode
surfaces, we fabricated a device and took impedance measurements before and after application of curing agent. With this device a heat cure was not performed, but instead the device
sat overnight at room temperature to complete the bonding step to decrease contamination
from the curing agent. The device still showed significant fouling after PDMS bonding as
shown by much increased double layer capacitance in buffer after PDMS application (see
Fig. 3.13b). The double layer capacitance is caused by effects on the electrode surfaces and
appears at higher frequencies which we see in Fig. 3.13b comparing buffer impedances before
and after curing agent (solid and dashed blue traces).

Figure 3.14: Q19’s sensing run with BSA and streptavidin.
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Curing agent appeared to be the source of the problems. Therefore we determined to
attach PDMS without using curing agent to bond the device. For this purpose we built an
acrylic clamp. Using only the clamp for PDMS to quartz attachment we tested several other
dies. However, the results of these experiments didn’t look promising either (see Fig. 3.14).
Neither the introduction of BSA or streptavidin changed the impedance through the sensor
much, as shown by the closely spaced results in both open and closed cases before and after
introduction of the biomolecules.

Figure 3.15: Impedance measurements before (blue and red traces) and after (green and
black traces) clamping PDMS onto a quartz sample.

In order to determine if the PDMS was out-gassing oligomers we scanned the impedance
before clamping PDMS onto the die, clamped a piece of PDMS on for an hour, then removed
the PDMS, and scanned again (see Fig. 3.15). Even without curing agent or a lengthy exposure time, PDMS appeared to be out-gassing onto the surface of the die and affecting the
impedance of the electrodes. This out-gassing happens because PDMS is mixed with curing
agent and the polymerization process leaves oligomers which can leach out. However, the
effect on the electrodes didn’t seem to be great, and in the buffer scans (red and blue traces
in Fig. 3.15) it even appeared to decrease the variance between electrode impedances.
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3.2

Microchannel impedance sensors

Figure 3.16: Mask for microchannel impedance sensor design, red areas are the etched microchannels.

We had developed a better understanding of curing agent and the consequences of
its use but this understanding still didn’t explain the results. The curing agent appeared
coat the electrodes but even when we took steps to minimize the coating we had inconsistent
results with BSA and streptavidin. We designed a simpler sensor for ease of analysis and
troubleshooting. This was accomplished by removing the interdigitated electrode fingers
and etching a channel (red area) between the electrodes (see Fig. 3.16). In conjunction
with the PDMS valves this would concentrate the ionic conduction path to the single etched
trench or microchannel connecting the electrodes. To test different microchannel widths and
electrode spacings, five designs were fabricated (see Fig. 3.16). One set of five designs was
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arranged under one PDMS valve while another set without etched trenches was placed as a
reference under the adjacent PDMS valve. The PDMS design remained unchanged from the
interdigitated electrode sensors.

(a) Impedance sensing results from NC1 Set 1.

(b) Impedance sensing results from NC2 Set 2.
Figure 3.17: Impedance sensing results from microchannel sensing runs.
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We ran tests on the microchannel sensors similar to those run on the other impedance
sensors. After protein introduction to the sensors the impedance between the electrodes
decreased in both runs (see Fig. 3.17a and Fig. 3.17b). The data from the second run in
particular (see Fig. 3.17b) indicated the PDMS was sealing off the microchannels themselves
as the black 30PSI traces look to follow a parasitic capacitance curve. This was likely
caused by the PDMS conforming over the edges of the electrodes or conforming into the
microchannel. This was a troubling development because it would make the sensor more
sensitive to changes in the PDMS conformation, actuation pressure, and small differences in
fabrication than the presence of biomolecules.

Figure 3.18: SEM images of NC1 and NC2 microchannel impedance sensors.

To gain a greater insight into the microchannel sensors and how the PDMS might
be conforming into the microchannels we took images of the sensors in a scanning electron
microscope (see Fig. 3.18). The images showed the gold electrodes didn’t connect at the microchannel sidewalls. This confirmed that it was possible for the PDMS to conform over the
electrode surfaces cutting off the electrodes from the microchannel and rendering impedance
measurements meaningless. Thicker electrodes were fabricated to coat the sidewalls but
they exhibited similar problems. Unfortunately much thicker films would likely delaminate
from the substrate despite the chrome transition layer beneath, especially with the added
mechanical stress of the PDMS valve actuations.
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(a) Fabricated nanochannel array.

(b) A fabricated PDMS valve placed over an array of nanochannels.

(c) PDMS valve actuated on an array of
nanochannels.
Figure 3.19: Microscope images of a nanochannel array and PDMS valves.
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3.3

Nanochannel impedance sensors: design A
The previous design had valves which could conform around the electrodes making

them inadequate for biomolecule detection. The trenches were also wide enough that the
PDMS valves could partially collapse into the opening. This partial collapse could introduce
more variability into sensing results as minute differences in actuation pressure, fluid pressure,
or valve seating could affect the resulting channel height. We developed a sensor where the
PDMS valve would close over a section of nano-trenches. These nano-trenches have widths
around a 100nms, much closer to the size of the proteins being detected, which should
provide much greater impedance changes after protein attachment. Fig. 3.19a shows the
location of a fabricated array of nano-trenches. The alignment marks are for working with
the Helios Nanolab 600 (FIB), in the center of the marks is a darker section of lines, this is
the nano-trench array. The newly designed PDMS valves didn’t close over the length of the
nano-trenches but left openings on both sides for ionic conduction through the newly formed
nanochannels. Fig. 3.19b shows the placement of the PDMS valve well within the alignment
marks while the nanochannel array extends beyond the marks. Fig. 3.19c shows an actuated
PDMS valve. The narrow trenches prevent the PDMS valves from varying significantly in
how deeply they conform into the trench openings.
After deciding to work on nanochannel sensors we designed a sensor on an one inch by
one inch quartz die with the hope of sensing a panel of twelve biomarkers. The promise was
not fulfilled in this iteration of the device. This particular device required some modification
to be able to detect any biomolecules at all due to a design flaw. It also demonstrated how
easily the nanochannel arrays could be multiplexed. As sometimes happens we were focused
almost entirely on the necessity of fabricating a new working PDMS valve that we neglected
to see the big picture. The flaw in this sensor is that while one side of the device had a
carefully fabricated column of nano-trenches and valves above them (right side of Fig. 3.20a
the fluidic channel is green while the valves are purple), on the other side of the valve was
another microchannel overlapping the same electrodes (the green line on the left in Fig.
3.20a) and guaranteed to have an impedance much lower than that of the nanochannels.
This lower impedance in parallel with the much higher nanochannel array impedance made
detecting changes in the nanochannel array practically impossible. This design flaw wasn’t
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(a) First generation nanochannel sensor and
PDMS schematic.

(b) Second generation PDMS schematic.
Figure 3.20: Schematic design of initial nanochannel sensors.

noticed immediately after testing started on the die because of another difficulty with the
design. The fluid channels were much smaller than we had used before and could only
handle much slower flow rate than previous designs. These flow rates required more time
per experiment and so we abandoned the larger PDMS piece for a smaller, more manageable
design (see Fig. 3.20b). Unfortunately this PDMS design also suffered from the same parallel
fluid channel flaw as the larger PDMS piece making meaningful sensing results difficult to
obtain.
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(a) Results of a nanochannel experiment with NC3
with Sensor 6.

(b) Results of a nanochannel experiment with NC3
with Sensor 7.

(c) Results of nanochannel buffer experiment with
NC3d.
Figure 3.21: Results of the first sets of nanochannel experiments and a later design.
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With the PDMS design, the results we got from the first nanochannel sensor were
exactly what we should have expected to get. The traces in air follow the parasitic capacitance curve and with fluid in the channels the impedance is considerably smaller (see
Fig. 3.21a and Fig. 3.21b). After the valves are actuated the impedance goes up, but only
slightly. This behavior is consistent with the lower impedance caused by the bypass channel
in parallel with the increased impedance on the sensing channel after the valves have been
actuated. Shortly after getting these results the flaw in the design was recognized.
This smaller PDMS could still be used to run a few tests, it needed only to be rotated
180◦ so the bypass channel was on the right side of the quartz die and didn’t electrically
connect adjacent electrode lines. The last graph shows the results from one of those runs (see
Fig. 3.21c). This is promising as the buffer trace from S6 with nanochannels (dashed red)
starts to look resistive at 100kHz, consistent with ionic conduction through the nanochannels. Even more promising is that S7 without nanochannels (dashed blue) followed the
parasitic capacitance curve closely, suggesting the PDMS valve electrically isolated adjacent electrodes. This isolation between non-nanochannel electrodes allowed us to trust the
nanochannel impedance we obtained.

Figure 3.22: Images of a PDMS valve at different actuation pressures 10PSI, 20PSI, 30PSI,
and 40PSI.

With this design we continued exploring how PDMS valves behaved in their dynamic
nanochannel function. Fig. 3.22 shows a series of the valves closing at different pressures.
To obtain reliable sensing results we desired PDMS valves which would close across the
nanochannel array consistently. As shown in Fig. 3.22 the valves didn’t close until after
30PSI, a much higher pressure than we desired. Our testing equipment wasn’t built to
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handle pressures around 40PSI. Working at that high of a pressure wasn’t desirable for
eventual use as a sensing platform either as it increases costs and complexity.
3.4

Nanochannel impedance sensors: H-Valve PDMS design

(a) Microscope image of fabricated Hbar valve.

(b) Results from H-Valve nanochannel characterization experiment.
Figure 3.23: A fabricated H-valve and results from a characterization experiment.
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Though the initial nanochannel sensors were promising, we wanted PDMS valves
which would close more reliably and at a lower actuation pressure. These valves needed to
be thin enough to fit over the milled nanochannel trenches and still close reliably. In the
earlier PDMS designs all valves were designed to have the same width as the channels they
were closing. To allow a significant amount of flow through the channel we wanted fluid
channels much wider than 100µm. With a valve width greater than 100µm it would require
nanochannels with lengths longer than 100µm and an array of hundreds of them to keep the
overall impedance of the nanochannels under the parasitic capacitance curve. Using the FIB
is more expensive and time consuming than other fabrication steps necessitating a design
with shorter nanochannel lengths. In addition to the practical cost and time considerations,
we believed from Fig. 3.22 that the parts of the microchannel channel hardest to seal were at
the edges (as seen in the 30PSI image). At the edges of the channels the PDMS membrane
is the thickest making them logically the hardest portion of the channel substrate for the
PDMS valve to collapse. Therefore we fabricated a ”H-valve” which closed parallel to the
channel with a narrow bar (see Fig. 3.23a) and much thicker regions on the sides. The
thickness of the narrow bar section of the H-valve varied from 25 − 75µm as we characterized
the new valve.
This valve closed, but also didn’t seal completely until 40PSI. Fig. 3.23b shows a
characterization run of the H-Valve PDMS design. As with the previous nanochannel design
at 40PSI in buffer the sensor with nanochannels goes resistive (solid red trace) under about
70kHz and without nanochannels (solid blue trace) looks capacitive. Unfortunately there is
a large gap between the 40PSI traces and the 30PSI traces (dotted yellow and dotted green)
suggesting they were only just closing over the nano-trenches. We reasoned it was because
the H-valve trapped fluid in the two pockets at the top and bottom of the ”H”. The fluid in
these pockets had a difficult time flowing under the wide valve regions when the valve was
actuated. After some consideration we truncated the top right and the bottom left portions
of the H-valve creating what we called the ”S-valve” which will be discussed in the following
chapter.
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Chapter 4
A Dynamic Nanochannel Array Sensor
In this chapter I report fabrication of a PDMS (polydimethylsiloxane) and quartz
dynamic nanochannel sensor and demonstrate the viability of the sensor with nonspecifically
bound BSA. The observed response is consistent with multilayer BSA coverage on the channel
walls.
Nanochannel sensors have much promise in biomarker testing; however, transporting
a significant number of biomakers at low concentrations to the sensor surfaces is challenging.
To help increase the volumetric flow rate and introduce biomolecules at a faster rate we
introduce the concept of dynamic nanochannels. These consist of nano-trenches where a
section of the open side can be dynamically sealed off to form nanochannels (see Fig.4.1).
To close the top opening of the nano-trenches a valve with a narrow bar 35µm wide is centered
on the nanochannels. When the valve is actuated an array of nanochannels is formed. To
ensure the only ionic path between the electrodes is through the nanochannels the valve also
seals off a portion of both ends of the microchannel. The microchannel allows for analyte to
be introduced to the top of the nano-trenches at flow rates higher than those achievable in
traditional nanochannel sensors. Unlike traditional nanochannels, all of the analyte is not
flowed through the nanochannels themselves, meaning the fluid should be recirculated for
optimal sample use. Thus dynamic nanochannels incorporate the advantages of the small
dimensions of traditional nanochannel impedance sensors for measurement purposes while
utilizing the high flow rates of microfluidic devices. As the nanochannels are located at the
bottom of the flow channels they don’t suffer from the strong shear forces the molecules in
traditional nanochannels can be exposed to.
The dynamic nanochannels are made with nano-trenches fabricated with a FIB in
a quartz substrate and a PDMS (Sylgard 184 kit; Dow Corning Corp.) valve situated
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Figure 4.1: A: Schematic diagram of device with two sensor regions, V1 and V2, both of
which are under PDMS valves. V2 has nanochannels etched into the quartz while V1 does
not. B: Top view of V2. C&D: Cross section views along dotted line in B for open and closed
conditions of the valve.

above them (see Fig. 4.1C). When the valve is actuated a section of the nano-trenches
is sealed forming nanochannels (see Fig.4.1D). With the valve open a microfluidic channel
is exposed allowing rapid transport of analyte to the surfaces of the nano-trenches (see
Fig.4.1B&C). The valve is composed of two PDMS layers: the fluid layer (red in Fig.4.1) and
the control layer (blue in Fig.4.1). The microchannels are formed in the fluid layer. Above
the microchannels the control layer has control channels filled with DI water. To actuate
the valve these channels are pressurized deforming the fluid layer membrane beneath and
sealing a section of the fluid channel (see Fig.4.1D).
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Figure 4.2: A: Microscope image of fabricated sensor region. B: Nano-trench array after FIB
milling. C: Close up of a single nano-trench.

To fabricate the sensor, first a 100mm quartz wafer (University Wafer) is dehydration
baked at 150◦ C for 10min. Surpass 4000 followed by a layer of AZ701 are spin coated onto
the wafer, each at 4000rpm. The wafer is then soft baked at 90◦ C for one minute. Next, a
10 second exposure is done with the mask containing the electrodes and the photoresist is
developed for 20 seconds in MIF300. We rinse with DI water followed by a thermal deposition
of 15nm of chrome and 150nm of gold onto the wafer. A lift-off is performed in an ultrasonic
bath for 20 minutes with Microposit 1165. After the lift-off the wafer is again rinsed with
DI water.
Nano-trenches are created by milling with a Focused Ion Beam (FIB). To decrease
charging during milling, a 32 nm layer of aluminum is first evaporated onto the wafer surface
using an electron-beam evaporator. A total of 141 lines are then milled into the quartz surface
with the FIB (see Fig.4.2B&C). The wafer is then placed in nanostrip for five seconds. After
being exposed to the nanostrip the wafer is rinsed in DI water. The aluminum layer is
completely removed by submerging the wafer in aluminum etchant for 15 minutes. Finally,
the wafer is rinsed with DI water, acetone and IPA (isopropyl alcohol) followed by a blow
dry with nitrogen gas.
The top or control layer of PDMS is fabricated with a 4:1 ratio of PDMS to curing
agent. The control channel mold is made with SU8-2025 and after fabrication had a thickness
of 24µm.
The PDMS for the fluidic layer is a 30:1 mixture of PDMS to curing agent. This
ratio made the PDMS exceptionally flexible to seal off the nanochannels when the valves
37

Figure 4.3: Impedance measurements for V1, V2 and fitted data. Solid lines are the measured
impedances, dashed lines are circuit equivalents. Green traces are the scans in air before
introducing fluid. The light blue curves are the fluid impedances with open valves. blue and
red traces are with the valves actuated, blue after BSA has been introduced and red before.
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were actuated. To make the mold for the fluidic layer, a four inch silicon wafer is baked
in the dehydration oven for ten minutes. HMDS is spun onto the surface at 4000 rpm for
one minute followed by a one minute bake at 90◦ C. SPR220-7.0 photoresist is then spun at
430 rpm for five seconds then 2000 rpm and 4000 rpm for 60 seconds each. A proximity
softbake is then performed at 115◦ C for 120 seconds. The wafer is then exposed to the
fluidic mask for 35 seconds at six mW/cm2 . After exposure the wafer is developed in MF24A for five minutes then rinsed in DI water and dried with nitrogen gas. The wafer is
then baked at 110◦ C for one minute to reflow the photoresist. Post reflow, the channel
mold has a semicircular profile with a height of 8µm and a width of 300µm. After mixing,
the PDMS solution is degassed for 50 minutes. The wafer is then silanized ((tridecafluoro1,1,2,2-tetrahydrooctyl)-1-trichlorosilane, UCT Specialties (Bristol, PA)) on a hotplate at
70◦ C for 10 minutes to decrease PDMS-to-mold binding. After which the PDMS is spun
onto the wafer at 500 rpm for five seconds followed by 4500 rpm for 60 seconds. An oven
bake at 80◦ C for 45 minutes is then performed.
After stamping with curing agent, the PDMS piece is bonded to the quartz piece
and cured on a hot plate at 70◦ C for 30 minutes [29]. The sensor is then clamped in an
acrylic holder with holes drilled in the top piece for the fluid and control lines. The clamp is
necessary to help the sensor valves to close fully in that there is no conduction path between
electrodes except through the nano-trenches in V2.
Impedance measurements are performed with an Agilent 4294A Impedance Analyzer.
4.3 shows the results of the impedance measurements taken (solid lines), as well as traces
representing an equivalent circuit (dashed lines). After an initial air scan (the trace labeled
”Air” in Fig. 4.3) the control channels are filled with DI water. Then a 1xPBS solution is
introduced to the sensors. Fluid is introduced via the Inlet (see Fig. 4.1). When changing
fluid a bubble separates the different sensing fluids. The bypass channel provides a path
for the bubble to flow through the device without interacting with the nano-trenches. A
Harvard Apparatus Pump (PHD 2000) pushes fluid through tubes into the device inlet at a
pressure of 25PSI. After the flow is stopped the clamp is tightened until V1 closes completely
when actuated as shown by the impedance measurement approaching 109 Ω at 100kHz. The
clamp remains at the same pressure for the remainder of the experiment. A series of scans
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are then conducted with the valves alternately open and closed with the valves pressurized
to 40PSI (1xPBS Open and 1xPBS Closed in Fig.4.3). A 1xPBS solution with 14µM BSA
is then flowed through the microchannel above the nano-trenches for 15 minutes. After BSA
exposure the channels are flushed with 1xPBS and a series of impedance scans are taken
(14µM BSA in Fig.4.3).
In the fabrication and testing process we discovered that it was a challenge to have a
PDMS valve seal completely to ionic conduction. Some iterations of the valves appeared shut
to flow but still had ionic conduction. Wide PDMS valves were easier to seal to ionic flow.
However we wanted the overall impedance of the nanochannels to be less than 10M Ω. We
could decrease impedance by adding more nanochannels or decreasing the width of the valve.
We settled on a 35µm valve width with 141 nanochannels, thereby allowing the nanochannel
impedance to be in the range we desired and keeping overall processing time down. To
enable this device to close reliably to ionic flow with a 35µm valve width we placed the
device in an acrylic clamp and actuated the valves at a pressure of 40PSI. The top side of
the clamp provided pressure and a solid surface to allow the valve to seal electrically. Due
to the pressure from the clamp and variations in the control layer thickness the microfluidic
channel partially collapsed in different areas of the die. These collapses led to different open
impedance measurements between V1 and V2.

Figure 4.4: Equivalent electrical schematic of the dynamic nanochannel sensor.
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An equivalent circuit model for the device is shown in Fig.4.4. There is a parasitic
capacitance (Cp ) associated with any electrical component. This capacitance sits in parallel
with the other circuit elements and sets an upper bound on the measurable impedance. Cp
is modeled by a 700fF capacitor (see Fig.4.3). There is also a double layer capacitance (Cdl )
representing the electrical double layer which forms on the surface of the electrodes. The
impedance of the double layer capacitance can be seen in the lower frequencies when the
valves are open (see Fig.4.3). Cdl corresponds to a 600pF capacitor. The 1xPBS solution
has a conductivity of 1.6 x10−2 S/cm [31]. When the valve is open this leads to a certain
impedance Rsol representing the impedance of the solution in the microchannel. When the
valve is closed (represented by the PDMS Valve switch in Fig.4.4) Rsol is then in series
with either an open circuit for V1 or the nanochannel resistance Rnc in V2. Rnc is much
greater than Rsol so changes in the ionic path through the nanochannels dominate the overall
impedance.
V1 is fabricated as a reference to ensure the PDMS valves seal completely to ionic
flow. When the valve is actuated the sensor impedance as a function of frequency looks
capacitive. This capacitive curve confirms the valve is an effective insulator between the
electrodes. With the valve open the impedance is higher than predicted. The resistance
between the electrodes with the valve open and a fluid channel with a height of 8µm should
have approximately 26kΩ of impedance, but we see a considerably higher impedance of
100kΩ. This is consistent with a channel height of 0.2µm, indicating that the flow channel
is largely collapsed in this region due to the pressure.
In the open case V2 has around 4x more impedance than calculated. The impedance
is consistent with a channel height of about 2µm. When closed, V2 behaves as expected.
Calculating the impedance of 141 nanochannels with height 380nm, width 65nm and length
of 35µm gives 7MΩ, which is consistent with the 5MΩ measured result. The difference is
to be expected as it would be surprising for the nanochannels to seal fully across the 35µm
width of the valve. A 5MΩ impedance corresponds to the valve sealing off 25µm of the
nanochannels (see Fig.4.1D). Once BSA has been introduced to the sensors the impedance
of the nanochannel array goes up to 11.5MΩ.
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The change in the ionic conduction path of a triangular nanochannel upon adsorption
of protein onto the walls is given by

w02
(w0 −2t)2

− 1 where w0 is the width of the nanochannel

opening and t is the thickness of the adsorbed protein layer. Using the impedance change
at 2kHz and assuming the protein layers are evenly distributed along the length of the
nanochannel walls with a width of 103nm and a depth of 380nm there is a layer of protein
18nm thick on the sensor walls (see Fig.4.5). BSA is has been reported to be between 4nm
and 8nm in diameter suggesting a multilayer covering of the protein on the channel walls
[28]. A 4nm monolayer of BSA covering the nanochannel walls should yield a 17% impedance
change.

Figure 4.5: Relative impedance change (
a function of frequency.

|Zf |−|Zi |
|Zi |

) from before and after BSA introduction as

The large relative change in nanochannel width equates to a large change in the
effective impedance of the device. At 2kHz the measured impedance change was 140%. Our
tests are run with a 1xPBS solution so surface effects on the electrodes or the nanochannel
surfaces themselves would not play an important role in the overall conductance [22].
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We introduced analyte to the sensors in only 15 minutes. The Hagen-Poiseuille law
for a rectangular pipe having a pressure drop of 25PSI across the length of the microchannel
with an average height of 2µm (calculated open height of V2) and width of 300µm the fluid
gives a volumetric flow rate of 5.75nL/s or an average velocity of 9.6mm/s. This high flow
velocity increased the rate of biomolecule attachment to nanochannel walls.
There are several paths towards improving the detection limits of dynamic nanochannels. The size of the bound biomolecule layers compared to the width of the nanochannels
determines the relative impedance change. By decreasing the width of the nanochannels
the impedance change can be increased. Moreover, after the biomolecules have adsorbed to
the nanochannel walls a large labeling molecule specific to the biomolecule could be flowed
and attach to the analyte. This would increase the effective size of the bound layer on the
surfaces, also greatly increasing the sensitivity. Another promising way to improve the dynamic nanochannel sensor would be to replace PDMS with another microfluidic material or
method which would more readily close to ionic flow.
In conclusion, we have built and tested a dynamic nanochannel sensor. This sensor
works by using valves and fluidics that are often already included on nanochannel devices.
The dynamic nanochannel sensor offers the measurement abilities of traditional nanochannel
sensors but also incorporates the increased flow speeds available with microfluidic devices.
These increased flow rates should allow the dynamic nanochannel sensor to detect concentrations of analyte which were previously impractical to detect using nanochannel impedance
sensing.
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Chapter 5
Biomolecular Flux and Detection Limits
The goal of this chapter is to determine the detection limit for the dynamic nanochannel channel sensor. The sensor’s detection method requires biomarkers to be immobilized
to the nanochannel walls by receptor molecules already bound to the walls. The bound
biomarkers will reduce the available volume for ionic conduction in the nanochannel. If
there are sufficient numbers of biomarkers immobilized this increased impedance can be
measured and the presence of the biomarker determined. As has been noted the biomarker
concentration required for medical purposes is often in the picomolar range. With these
concentrations, attaching a significant number of biomarkers to the sensor walls becomes a
challenge. Therefore, quantifying the number of biomarkers that attach to the sensor wall for
a given concentration is crucial in determining detection limits for the dynamic nanochannel
sensor. In addition, the variability when actuating the PDMS valve between successive runs
will play a role in determining the minimum detectable impedance change.
When working with picomolar concentrations, the rate of molecules attaching to the
sensor surfaces often becomes the limiting factor in sensing applications. In the case of typical
static nanochannel sensors, unless the fluid has a velocity greater than several millimeters
per second, all of the analyte within the sample volume will encounter the sensor walls [23].
With these flow rates all of the biomarkers have the ability to bind making static nanochannel
sensors very efficient with sample volume. The HagenPoiseuille equation relates fluid channel
dimensions to pressure and fluid flow [32]. As electricity was historically considered a fluid
these terms relate easily to circuit terminology with pressure drop corresponding to voltage,
volumetric flow rate to current and channel dimensions in conjunction with the viscosity
of the fluid providing the analogue to resistance. Nanochannels correspond to very high
impedance resistors. Ohm’s law tells us V = IR or I =
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V
;
R

the flow resistance of static

(a) Slice showing velocity profile through an opening dynamic
nanochannel sensor.

(b) Slice showing concentration densities in the sensor.
Figure 5.1: COMSOL simulations of the velocity profile and concentration profile above the
nanochannels.
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nanochannels is very high necessitating high pressures to attain substantial volumetric flow
rates. Thus the limitation Schoch et al. encountered to higher volumetric flow rates came
from the amount pressure their pump was able to supply [23]. If a large volumetric flow rate
is attained then the nanochannel dimensions require the fluid passing through the channels
to have exceptionally large linear velocities. These velocities mean there will be considerable
shear forces on the attached biomolecules, enough even to detach bound protein [23]. These
two opposing forces mean there is a flow rate where biomolecular flux will be optimized in
static nanochannels. They also limit the quantity of analyte which can be introduced to the
nanochannels within a given time period.
The COMSOL Multiphysics simulation platform was used to determine flow rate
over the channels and molecular flux to the nanochannel walls (see Fig. 5.1a and Fig.
5.1b). A slice of the nanochannel array sensor with three nanochannels placed under a two
micrometer fluidic channel was modeled. The nanochannel walls were given a boundary
condition where they would simulate a surface functionalized with binding probabilities
given by their respective Kd . The top and bottom of the fluidic channel were given no slip
boundary conditions and treated as passivated to the target analyte. Fluid entered on the
left with a velocity simulated using the pressure drop across the length of the section and
the channel dimensions. The pressure difference used of 90 Pa was calculated by taking the
total pressure drop across the length of the fluidic channel divided by the relative length of
the simulated section. The center of the flow channel sees the highest flow velocities (in red
image Fig. 5.1a). This can be increased to more than 10mm/s with a reasonable channel
height (2µm). The nanochannels are not in main flow region, but rest below it. Because of
their location in the flow channel many of the target analyte molecules don’t interact with
the nanochannel sensor walls as they pass the nanochannels. This has a detrimental effect on
sample use though recirculation valves could help alleviate this problem. Although dynamic
nanochannel sensors use of sample volume is not as efficient as other nanochannel sensors,
they keep the nanochannel walls from being exposed to the shear forces from high velocity
flow.
Once biomolecules have been transported to the surface of nanochannel walls they
must attach to occlude ion transport. The probability of a molecule attaching to a surface
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Figure 5.2: Simulated flux to the nanochannel surfaces with dynamic nanochannel sensors
versus those reported in literature. Molecular Flux refers to the number of molecules attaching
to a single nanochannel.

depends primarily on if the surface has been functionalized for that analyte and the dissociation constant Kd between the receptor and the analyte. The sensor described in the
previous chapter depended on non-specific binding which slowed down the reaction time.
Kd describes the critical concentration in the fluid at which there will be 50% coverage of
the analyte on the sensor walls. This number varies depending on the receptor and analyte
chosen. For BSA attaching nonspecifically to quartz the dissociation constant is 200nM; for
streptavidin attaching specifically to biotin Kd is 1fM, six orders of magnitude lower and
virtually guaranteeing all streptavidin which encounters the biotin attached to the nanochannel walls will bind and remain. Fig. 5.2 shows the simulated flux density to one dynamic
nanochannel compared to a static nanochannel sensor. Use of a flow channel situated above
the nanochannels allows for greater than a two order of magnitude increase in the number
molecules being transported to the nanochannel surfaces. These simulations are in accord
with limits described in literature [33].
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Figure 5.3: Response times with a different Kd this modeling streptavidin binding to biotin
attached to the sensor surfaces.

The detection limit of the dynamic nanochannel sensor depends on the number of
biomolecules which attach to the sensing surfaces and the sensitivity of the transduction
method. Figure 5.3 shows an example of the biomolecules which attach in a single nanochannel using the strong biotin-streptavidin bond in the model. The linear slope of the lines
represents the molecular flux density. The valves offer the advantage of increasing the number of molecules which can be attached to the sensor walls in a given time period, but the
PDMS valves so far have decreased the sensitivity of the impedance scans relative to static
nanochannel sensors because they introduce variability. In Fig. 5.3 the minimum detectable
limit is set by taking three times the standard deviation of that variability. This variability comes from the elastomeric PMDS membrane sealing differently between scans. Several
factors appear to be influencing this effect. The first is that the valve takes time to seal
completely and there is a time delay in the valve sealing to ionic flow. During testing of the
sensor in the previous chapter scans were taken 30 seconds after the valves were actuated.
However the timing of this process was not automated and therefore inconsistent. The scans
were taken over a wide range of frequencies which gave information useful for constructing
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an equivalent circuit but increased the time needed per scan. In addition to the time component of the valves closing they are also sensitive to slight variations in the fluid pressure
after different fluids have been introduced to the sensor. These variations change the pressure needed to fully close a valve. Finally pieces of debris which would have been removed
had we employed an in-chip filter could lodge under the valve affecting its function. These
effects worked to decrease the consistency of the valves in our fabricated proof of concept
device compared to static nanochannel sensors. However these are not insurmountable challenges. With a valve design more suited to decreasing variations, and more careful control
of fluid pressure the variability of the device could be vastly decreased, giving the sensor
transduction characteristics more similar to static nanochannel sensors.
Due to the PDMS valves the variability of the device tested in Chapter 3 was higher
than desired. Three times the average variability was used as the detection threshold and
was equivalent to the change in the impedance signal with about 40% of the available binding
sites filled. If the surface was functionalized with biotin and streptavidin was flowed through
the channels a 20pM concentration of streptavidin should be detectable in 40 minutes (see
Fig. 5.3). This detection limit is due to the high binding affinity of streptavidin to biotin.
If the variability of the system was decreased an order of magnitude, which is reasonable
with redesigned valves, then a 2pM concentration of streptavidin becomes detectable in 40
minutes. A picomolar concentration is the level given by Diamandis for many biomarker
concentrations in serum [5].
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Chapter 6
Conclusion
Widespread proteomic biomarker screening has the capability to save thousands of
lives a year. Its potential impact in decreasing cancer-related suffering in the United States
alone is enormous. Sensitive, inexpensive sensors are key to allowing proteomic biomarkers
to realize their potential in these applications. Such sensors should be able to inexpensively detect proteomic biomarkers in picomolar concentrations or less. Impedance spectroscopy sensing is one of the least expensive transduction methods available while providing
a straightforward detection model.
Unfortunately, fabricating and testing a dynamic nanochannel sensor was not as
straightforward as the conceptual model. During the experiments there were many unexpected roadblocks. Milling nano-trenches turned out to be slow and expensive. It happened that PDMS isn’t ideal for impedance sensing. The curing agent used for PDMS
to quartz bonding tended to contaminate sensor surfaces while the PDMS-based valves
wouldn’t easily seal to ionic flow, making consistent impedance measurements difficult. To
detect biomolecules as small as proteins we needed the conduction channel to have a critical
dimension on the order of tens of nanometers leading to the eventual design of dynamic
nanochannel array sensors.
Finally we designed, fabricated, and testing a working dynamic nanochannel sensor.
Using PDMS at the limits of its abilities, the control valve closed to ionic flow and we
measured protein capture to nanochannel walls. This sensor gave a higher than expected
response to non-specifically bound BSA to the nanochannels walls. When opened, the dynamic nanochannel sensors should allow more molecules to bind to nanochannel surfaces
compared to static nanochannel designs. This improvement comes due to the much larger
microfluidic flow channels of the dynamic nanochannel sensors. With these flow velocities
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and sensor geometry the fabricated sensor, if functionalized, should be able to detect protein
concentrations in the tens of picomolars.
While several biomarkers present in the concentration range of tens of picomolars
there is a clear path to increase the sensitivity of the device even lower. First, the valves
should be updated. PDMS is not ideal for dynamic nanochannel sensors due to non-specific
binding issues [34], curing agent contamination, out-gassing, and difficulty sealing to ionic
flow. A new microfluidic polymer should allow for a valve which will close quicker and more
consistently to ionic flow. Improvements with the valve would increase the sensitivity of the
device dramatically. Other future work on the dynamic nanochannel sensor array includes
developing an E-beam lithography step for patterning the nanochannels to reduce fabrication cost and time. As mentioned in the background chapter, the ratio of the width of the
nanochannel to the occluded area of the biomarker determines the impedance change per attached molecule. The widths of the nanochannels could be optimized further by accounting
for the relative impedance change for a given biomolecule and its diffusion constant. Developing an amplification step using gold nanoparticles or other similar particles could also
drastically increase the sensitivity of the device [27]. After the sensitivity of the dynamic
nanochannel arrays has been optimized, functionalizing the arrays for a panel of biomarkers
would be the next step. Including many sensors multiplexed on a single chip could then be
accomplished. Once the sensors are proven to work with a panel of biomarkers in serum the
final step would be to package the sensors with a hand-held or table-top all-in-one measurement device. The beauty of the impedance sensor is that these final steps of multiplexing
and packaging should be straightforward.
With these steps completed the dynamic nanochannel would be a powerful and inexpensive tool for widespread biomarker screening allowing vastly improved prognosis for
many who suffer.
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